We are live on ! Find out more
Marshall Wace

Marshall Wace Portfolio holdings

AUM $100B
1-Year Est. Return 35.1%
This Fund
S&P 500
This Quarter Est. Return
+3.64%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$74.9B
AUM Growth
+$9.23B
Cap. Flow
+$7.27B
Cap. Flow %
9.7%
Top 10 Hldgs %
32.66%
Holding
3,137
New
748
Increased
792
Reduced
857
Closed
654

Top Buys

Rank Stock Value
1
IVV icon
iShares Core S&P 500 ETF
IVV
+$3.04B
2
MSFT icon
Microsoft
MSFT
+$830M
3
AMZN icon
Amazon
AMZN
+$550M
4
JNJ icon
Johnson & Johnson
JNJ
+$483M
5
AAPL icon
Apple
AAPL
+$470M

Sector Composition

Rank Sector Weight
1 Technology 18.7%
2 Consumer Discretionary 13.75%
3 Healthcare 12.4%
4 Financials 7.81%
5 Industrials 6.28%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CPT icon
1801
Camden Property Trust
CPT
$11.2B
$696K ﹤0.01%
+6,381
New +$659K
KBWB icon
1802
Invesco KBW Bank ETF
KBWB
$6.88B
$696K ﹤0.01%
+13,003
New +$686K
INBK icon
1803
First Internet Bancorp
INBK
$231M
$695K ﹤0.01%
25,713
-4,889
-16% -$148K
CVCO icon
1804
Cavco Industries
CVCO
$4.46B
$692K ﹤0.01%
+1,999
New +$727K
LRMR icon
1805
Larimar Therapeutics
LRMR
$398M
$690K ﹤0.01%
95,214
-4,574
-5% -$35K
CRWD icon
1806
PUT
CrowdStrike
CRWD
$183B
$690K ﹤0.01%
7,200
-64,400
-90% -$5.35M
TXG icon
1807
10x Genomics
TXG
$5.83B
$689K ﹤0.01%
+35,401
New +$927K
MGX icon
1808
Metagenomi Therapeutics
MGX
$45.6M
$688K ﹤0.01%
168,639
-14,388
-8% -$98.9K
SWX icon
1809
Southwest Gas
SWX
$6.66B
$686K ﹤0.01%
9,743
-8,895
-48% -$666K
UNFI icon
1810
United Natural Foods
UNFI
$2.97B
$681K ﹤0.01%
52,001
-6,080
-10% -$68.3K
CITEW
1811
CALL
DELISTED
Cartica Acquisition Corp Warrant
CITEW
$681K ﹤0.01%
60,000
-154,130
-72% -$12.4K
PSMT icon
1812
Pricesmart
PSMT
$5.81B
$681K ﹤0.01%
8,385
+4,067
+94% +$335K
FIVN icon
1813
FIVE9
FIVN
$1.96B
$679K ﹤0.01%
15,403
-190,730
-93% -$9.91M
RECS icon
1814
Columbia Research Enhanced Core ETF
RECS
$5.9B
$677K ﹤0.01%
20,982
+2,959
+16% +$91.9K
ILCG icon
1815
iShares Morningstar Growth ETF
ILCG
$3.09B
$676K ﹤0.01%
8,300
-1,490
-15% -$114K
ALG icon
1816
Alamo Group
ALG
$2B
$675K ﹤0.01%
3,904
+1,893
+94% +$369K
EHTH icon
1817
eHealth
EHTH
$43.2M
$675K ﹤0.01%
+148,931
New +$750K
XHR
1818
Xenia Hotels & Resorts
XHR
$2B
$672K ﹤0.01%
+46,891
New +$679K
WF icon
1819
Woori Financial
WF
$16.4B
$672K ﹤0.01%
+20,961
New +$656K
ICUI icon
1820
ICU Medical
ICUI
$4.04B
$671K ﹤0.01%
5,647
-54,007
-91% -$5.68M
CCO icon
1821
Clear Channel Outdoor Holdings
CCO
$1.23B
$671K ﹤0.01%
+475,545
New +$701K
AWI icon
1822
Armstrong World Industries
AWI
$7.05B
$669K ﹤0.01%
5,910
+2,306
+64% +$267K
HZO icon
1823
MarineMax
HZO
$799M
$669K ﹤0.01%
+20,661
New +$606K
LNTH icon
1824
Lantheus
LNTH
$7.03B
$668K ﹤0.01%
8,326
-448,736
-98% -$32.9M
CSTM icon
1825
Constellium
CSTM
$4.02B
$668K ﹤0.01%
+35,439
New +$737K

Similar funds

Marshall Wace's Q2 2024 Portfolio in Review

As of Q2 2024, Marshall Wace held 3,137 positions worth $74.9B, up 14% from $65.7B the previous quarter. Its ten largest holdings account for 33% of the portfolio.

Marshall Wace deployed $7.27B of net new capital in Q2 2024, opening 748 new positions and adding to 792 existing holdings. Its largest new stake was GE Vernova: 2,330,887 shares worth $400M.

By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 16% a quarter earlier, followed by Consumer Discretionary and Healthcare.

On the sell side, the largest reduction was Procter & Gamble, an estimated $474M trimmed.

  • Marshall Wace's largest Q2 2024 buy was GE Vernova: 2,330,887 shares worth $400M.
  • Marshall Wace added most to iShares Core S&P 500 ETF in Q2 2024, an estimated $3.04B increase.
  • Marshall Wace's biggest Q2 2024 reduction was Procter & Gamble, cutting an estimated $474M.
  • Marshall Wace fully exited Applied Materials in Q2 2024, selling an estimated $127M.
  • Marshall Wace's ten largest holdings make up 33% of its $74.9B portfolio in Q2 2024.
  • Marshall Wace opened 748 new positions and closed 654 in Q2 2024.
  • Marshall Wace's portfolio value rose 14% quarter-over-quarter to $74.9B.

Based on Marshall Wace's 13F filing for Q2 2024, filed 14 Aug 2024.